The Canadian Association of Radiation Oncology and Elekta Award Research Fellowship

Radiation oncology and medical technology groups award the second annual CARO-Elekta Research Fellowship to Dr. Scott Carlyle Morgan Vancouver, BC – The Canadian Association of Radiation Oncology (CARO), along with international medical-technology group Elekta, are pleased to award the 2008 CARO-Elekta Research Fellowship to Radiation Oncologist, Dr. Scott Carlyle Morgan. The ,000 fellowship, provided by Elekta, will enable Dr. Morgan to conduct research with the Uro-Oncology Unit at the Royal Marsden Hospital in London, England with Professor David Dearnaley. His research will revolve around a newly emerging approach to treating prostate cancer that involves the delivery of very precise radiation treatment only to regions of the prostate gland that harbour cancer. He is scheduled to begin his research in November 2008. Radiation oncology and medical technology groups award the second annual CARO-Elekta Research Fellowship to Dr. Scott Carlyle Morgan Vancouver, BC – The Canadian Association of Radiation Oncology (CARO), along with international medical-technology group Elekta, are pleased to award the 2008 CARO-Elekta Research Fellowship to Radiation Oncologist, Dr. Scott Carlyle Morgan. The ,000 fellowship, provided by Elekta, will enable Dr. Morgan to conduct research with the Uro-Oncology Unit at the Royal Marsden Hospital in London, England with Professor David Dearnaley. His research will revolve around a newly emerging approach to treating prostate cancer that involves the delivery of very precise radiation treatment only to regions of the prostate gland that harbour cancer. He is scheduled to begin his research in November 2008.

This is the second year that the CARO-Elekta Research Fellowship Program has been awarded.  The fellowship will provide research and salary support to Dr. Morgan for a period of one year, with the potential to renew for a second year.  His research is endorsed by both CARO and Elekta as being particularly relevant to the current and future practice of radiation oncology.

We are thrilled that CARO is able to offer this fellowship in conjunction with Elekta for a second year,” said Dr. Michael Milosevic, President of the Canadian Association of Radiation Oncology.  “This fellowship program enables deserving individuals such as Dr. Morgan to conduct significant research and further their training and development in radiation oncology.

The first ever CARO-Elekta Fellowship was awarded in 2007 to Dr. Jason Pantarotto.  The award allowed him to conduct research at the Vrije University Medical Centre in Amsterdam, The Netherlands associated with new technologies being used in the treatment of lung tumours.  He worked on a number of projects related to 4-dimensional radiotherapy, and earlier this year, he presented an abstract on adaptive radiotherapy planning for lung cancer at the European Lung Cancer Conference in Geneva, Switzerland.  Dr. Pantarotto completed his research earlier this summer.  He will be presenting three papers arising from his fellowship work at the forthcoming Canadian Association of Radiation Oncology Annual Scientific Meeting in Montreal, September 11-13, 2008.

This year’s fellowship will provide Dr. Morgan with the opportunity to work at the Royal Marsden Hospital in London, England. The overall goal of his research will be improving the probability to control tumours within the prostate gland without increasing the side effects of radiation treatment.  During the course of the fellowship, his team will conduct a clinical trial involving new imaging techniques for identifying prostate cancer within the prostate gland and precisely targeting these regions of cancer with radiation treatment.

The Uro-Oncology Unit at the Royal Marsden Hospital has an impressive track record in clinical trials,” said Dr. Morgan.  “Many groundbreaking randomized trials in urological radiation oncology have been led by their investigators.  The opportunity to work with and learn from such a talented group of oncologists and trialists is exciting.  I am grateful to CARO and Elekta for the opportunity to pursue the fellowship.

Dr. Morgan holds degrees in engineering physics (UBC, 1999) and medicine (Queen’s University, 2003).  He completed his residency at the University of Ottawa and obtained his fellowship in Radiation Oncology from the Royal College of Physicians and Surgeons of Canada in June of this year.

About the Canadian Association of Radiation Oncology

The Canadian Association of Radiation Oncology (CARO) is the official voice of radiation oncology in Canada.  CARO interacts with the Royal College of Physicians and Surgeons, the Canadian Medical Association, the Canadian Association of Medical Radiation Technologists, the Canadian Organization of Medical Physicists, provincial cancer agencies, government health bodies and other national organizations on issues affecting services for the control of cancer in matters related to radiation oncology.  CARO conjointly accredits training programs for radiation oncology related health care professionals.  For more information about CARO, please visit www.caro-acro.ca .

About Elekta

Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state-of-the-art tools to fight serious disease.  Elekta provides advanced clinical solutions, comprehensive management and information systems, as well as services for improved cancer care and management of brain disorders.

Elekta’s systems and solutions are usedin more than 5,000 hospitals around the world.  Clinical and information management solutions include, among others, Leksell Gamma Knife® for non-invasive treatment of brain disorders, Elekta Axesse™ and Elekta Synergy® for stereotactic and image guided radiation therapy and radiosurgery, as well as the MOSAIQ® suite of software for image-enabled EMR and efficient management of clinical and patient data.

With more than 2,500 employees globally, Elekta corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb.

About the CARO-Elekta Research Fellowship Program

The CARO-Elekta Research Fellowship Program is a unique opportunity for CARO and Elekta to foster the development of highly qualified clinicians and researchers. The goal of the program is to provide an opportunity for individuals who have completed their Radiation Oncology training in Canada to undertake additional clinical and/or translational research training in Canada or abroad.  The inaugural CARO-Elekta Fellowship was awarded in 2007.

For more information, please contact:

Susan Broadbear
Association Manager
Canadian Association of Radiation Oncology
600 West 10th Avenue
Vancouver, BC   V5Z 4E6
Canada
Phone: (604) 877-6193
Email: sbroadbe@caro-acro.ca

Michelle Lee
PR and Advertising Manager
Elekta, Inc.
4775 Peachtree Industrial Boulevard
Building 300, Suite 300
Norcross, Georgia   30092
USA
Phone: (770) 670-2447
Email: michelle.lee@elekta.com